Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study

from TheBrief.Health · host TheBrief.Health

Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.

Episode metadata supplied by the publisher feed · Published May 15, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study

0:00 1:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 15, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!